Actively Recruiting
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
Led by Johns Hopkins University · Updated on 2025-11-10
360
Participants Needed
2
Research Sites
157 weeks
Total Duration
On this page
Sponsors
J
Johns Hopkins University
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate the effectiveness of a social network intervention to recruit people who inject drugs and their networks for HIV testing and linkage to HIV prevention and treatment services in Maryland. Study aims are to determine the effectiveness of a social network driven intervention to increase: * HIV testing (primary); * PrEP knowledge; * Uptake of HIV services and pre-exposure prophylaxis (PrEP); * Uptake of medication for opioid use disorder (MOUD) initiation. Eligible participants who access syringe service programs (SSPs) serving two counties in Maryland and their risk network members (NMs) will be recruited using an established network inventory and coupon recruitment method. When an index successfully recruits NMs, the index-NM cluster will be randomized to either a peer-educator intervention arm or an equal-attention control arm. Index participants randomized to the peer-educator intervention arm will complete a training program adapted with stakeholder input to context that emphasizes effective communication, frequent HIV testing, and awareness of evidence-based HIV prevention and treatment services. An important innovation to the network intervention will be training indexes to use and distribute HIV self-test kits and naloxone to their NMs. Index participants randomized to the equal-attention control arm will receive training sessions focused on the opioid overdose epidemic and will not include any training to serve as a peer educator. All participants (indexes and NMs) will complete study assessments at baseline and at 3 and 9 months. We will compare the peer-educator intervention group and the equal-attention control group on rates of HIV testing, knowledge of PrEP options and resources, and rates of initiation of HIV treatment, PrEP, and MOUD treatment since the previous assessment (past 3 or 6 months).
CONDITIONS
Official Title
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be 18 years or older
- Self-report injection drug use in the prior month
- Have accessed services at the syringe service program in the prior 3 months
- Willing to undergo training and attend weekly booster group sessions
- Able to recruit at least 1 drug use network member into the study
- Willing to talk with peers about injection drug use topics such as HIV prevention and care
- Not previously enrolled in the study as an index or network member
- English-speaking
You will not qualify if you...
- Individuals lacking the capacity to consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287
Not Yet Recruiting
2
Frederick County Health Department, Street Safe Program
Frederick, Maryland, United States, 21701
Actively Recruiting
Research Team
O
Oluwaseun Falade-Nwulia, MBBS, MPH
CONTACT
G
Gregory Lucas, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here